Gleason Group, Inc. Gsk PLC Transaction History

Gleason Group, Inc.

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 13, 2022	BUY	$42.05 - $47.77 $7,779 - $8,837	185 Added 1.29%	14,560 $634,000
Q1 2022 Apr 22, 2022	BUY	$40.23 - $47.74 $6,396 - $7,590	159 Added 1.12%	14,375 $626,000
Q4 2021 Jan 18, 2022	BUY	$38.88 - $45.31 $7,153 - $8,337	184 Added 1.31%	14,216 $627,000
Q3 2021 Oct 12, 2021	BUY	$38.79 - $43.16 $6,943 - $7,725	179 Added 1.29%	14,032 $536,000
Q2 2021 Jul 27, 2021	BUY	$36.52 - $41.46 $8,582 - $9,743	235 Added 1.73%	13,853 $552,000
Q1 2021 Apr 14, 2021	BUY	$34.27 - $40.01 $56,853 - $66,376	1,659 Added 13.87%	13,618 $486,000
Q4 2020 Jan 28, 2021	BUY	$34.07 - $39.94 $5,178 - $6,070	152 Added 1.29%	11,959 $440,000
Q3 2020 Oct 15, 2020	BUY	$38.11 - $42.99 $5,182 - $5,846	136 Added 1.17%	11,807 $444,000
Q2 2020 Aug 27, 2020	BUY	$37.87 - $43.58 $6,286 - $7,234	166 Added 1.44%	11,671 $476,000
Q1 2020 Aug 27, 2020	BUY	$32.47 - $48.83 $3,896 - $5,859	120 Added 1.05%	11,505 $436,000
Q4 2019 Aug 27, 2020	BUY	$42.0 - $48.25 $478,170 - $549,326	11,385 New	11,385 $535,000

176K

Ticker GSK
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,033,689,984
Market Cap $69.3B
Description
GSK plc, together with its subsidiaries, engages in the creation, discovery, development, manufacture, and marketing of pharmaceutical products, vaccines, over-the-counter medicines, and health-related consumer products in the United Kingdom, the United States, and internationally. It operates through four segments: Pharmaceuticals, Pharmaceutic...

Get notified when there are updates to the investment portfolio of Gleason Group, Inc., based on Form 13F filings with the SEC.

Stay updated on Gleason Group, Inc. with notifications on news.